Physician profile
Eric M Pachter
NPI 1922068436
$2,519.68
in general payments reported to CMS, 2019-2025
15 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $835 · 2020: $153 · 2021: $344 · 2022: $276 · 2023: $295 · 2024: $497 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $828 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $827.54 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $621.56 | 2019-2021 | |
| Janssen Biotech, INC. | $430.73 | 2019-2025 | Erleada |
| Teleflex LLC | $292.69 | 2022-2024 | Urolift |
| Endo Pharmaceuticals INC. | $191.25 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $179.48 | 2022-2024 | |
| Abbvie INC. | $162.22 | 2019-2022 | |
| Antares Pharma, INC. | $157.93 | 2021-2023 | Nocdurna, Tlando, Xyosted |
| Procept Biorobotics Corporation | $156.49 | 2024 | Aquabeam System |
| Pfizer INC. | $139.79 | 2019-2024 | |
| Halozyme INC | $82.78 | 2023 | |
| Axonics, INC. | $39.15 | 2021-2023 | Axonics |
| Olympus America INC. | $20.92 | 2024 | Itind System |
| Myovant Sciences INC. | $17.10 | 2021 | |
| Angiodynamics, INC. | $15.30 | 2025 | Nanoknife |
| Urogen Pharma, INC. | $12.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Pachter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.